Author

Xiao Ma

Mayo ClinicORCID 0000-0001-9940-8468Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiao Ma6 papers · Ghent University

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1 Organism:zebrafish· 1

Frequent Co-Authors

Alexey V. DvornikoviD· 1 shared Carlos Maria FerrarioiD· 1 shared Dante G. MoroniiD· 1 shared Hong ZhangiD· 1 shared Horng H. CheniD· 1 shared Joerg HerrmanniD· 1 shared John C. Jr BurnettiD· 1 shared Lianwen ZhangiD· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Alexey V. DvornikovORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJan 26, 2023

EVIDENCE FOR ANGIOTENSIN II AS A NATURALLY EXISTING SUPPRESSOR FOR THE NATRIURETIC PEPTIDE SYSTEM

Xiao Ma, Seethalakshmi R. Iyer, Xiaoyu Ma…·John C. Jr Burnett

This study provides evidence that angiotensin II suppresses the natriuretic peptide system by inhibiting cGMP production via AT1 receptor and PKC, supporting dual-targeting therapies for cardiovascular disease.

DOI 10.1101/2023.01.26.525806

humanproteomics

𝕏 PostBluesky

GeneticsbioRxivPreprintDec 8, 2018

Retinoid X receptor alpha is a spatiotemporally-specific therapeutic target for doxorubicin-induced cardiomyopathy in adult zebrafish

Xiao Ma, Yonghe Ding, Hong Zhang…·Xiaolei Xu

This study identifies RXRA as a therapeutic target for doxorubicin-induced cardiomyopathy in zebrafish by showing its endothelial-specific function and response to FDA-approved agonists.

DOI 10.1101/490706

zebrafishexperimental assay

𝕏 PostBluesky